Along with these six shared antigens, additional valuable markers (e.g., CD22 and CD81) were frequently included in the optimized tubes, while other B-ALL diagnostic markers, such as CD79a, TdT and CD24, were more often found to be poorly informative for MRD assessment. Here, CD81 is linked to precursor B-cell acute lymphoblastic leukemia.